Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natriuretic Effect of Telmisartan in Hypertension
NCT02176499Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 1999
- Primary completion
- Jul 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Feb 1999; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02176499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176499.